Barriers and Facilitators to MMR Vaccination Among Healthcare Workers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

23 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-12

Study Completion Date

2024-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measles is a highly contagious disease which can result in severe complications in some patients. Healthcare workers have a higher risk of getting measles than the general population because of their increased risk of exposure from patients with measles attending hospitals. Having had measles in the past or at least one dose of the measles, mumps and rubella (MMR) vaccine provides protection (immunity) against measles. UK government guidelines therefore recommend that healthcare workers and non-clinical staff with direct patient contact are fully vaccinated or have other evidence of immunity. Yet, evidence from recent measles outbreaks suggests that some healthcare workers are not immune or do not know if they are immune, with implications for containment efforts, cost and transmission. The purpose of this study is to identify barriers and facilitators to uptake of the MMR vaccine among healthcare workers at King's College Hospital NHS Foundation Trust (KCH). KCH healthcare workers will be eligible to take part in the study if they are aged 18 and over and have direct contact with patients. In addition, the research will focus on four subgroups of healthcare workers at KCH: those who are not immune, those who have not completed the full vaccination schedule, those who don't know their immunity status, those received the vaccine only after joining KCH. The latter may provide insights into facilitators to vaccine uptake. Measles immunity forms part of the occupational health screening at KCH. A series of semi structured interviews lasting approximately 1 hour will explore participants' experiences of the occupational health vaccine screening process and measles vaccine campaigns at KCH; why they are unvaccinated/not fully vaccinated/do not know if they are immune/decided to be vaccinated after joining KCH; and what measures or interventions may help healthcare workers when deciding whether to get the MMR vaccine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measles, Mumps, and Rubella (MMR) Immunity in College Students

NCT00962819

Measles Mumps Rubella

COMPLETED

Measles Vaccination at Health System Contacts

NCT04220671

Measles Vaccine Hospital Admission Mortality +1 more

ENROLLING_BY_INVITATION PHASE4

Measles Vaccine in HCW

NCT04357028

Covid19

SUSPENDED PHASE3

Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings

NCT06667206

Measles

RECRUITING PHASE2

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

NCT01602094

Measles

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Measles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthcare workers

Healthcare workers at one Trust who have direct patient contact and fall within one of four groups: 1) they are not immune to measles (have not had measles in the past and have not been vaccinated with both doses of the MMR vaccine), 2) they have not completed the full vaccination schedule (they have received only 1 dose of the MMR vaccine), 3) they do not know their immunity status, and 4) they received the MMR vaccine after joining the Trust.

MMR vaccination

Intervention Type BIOLOGICAL

MMR vaccination status

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MMR vaccination

MMR vaccination status

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are aged 18 and over
* Currently work as a healthcare worker at the Trust
* Have direct contact with patients
* Don't know if they have had measles and don't know if they have been vaccinated
* Or: Have not had measles and have not received the MMR vaccine
* Or: Have only received 1 dose of the MMR vaccine
* Or: Received the MMR vaccine after joining the Trust

Exclusion Criteria

* Are aged \<18 years old
* Work in a role at the Trust that does not involve direct contact with patients (e.g., administrative or business staff)
* Are sure and/or have evidence that they have had measles in the past or both doses of the MMR vaccine before joining the Trust
* Are not able to give informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No